Systemic Scleroderma clinical trials at UCSF
1 in progress, 0 open to eligible people
A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis
Sorry, in progress, not accepting new patients
The main objective is to assess long term safety of treatment with oral nintedanib in patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD).
San Francisco, California and other locations